Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Bleakley Financial Group LLC

Bleakley Financial Group LLC boosted its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 1.2% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 757 shares of the medical instruments supplier’s stock after purchasing an additional 9 shares during the period. Bleakley Financial Group LLC’s holdings in Mettler-Toledo International were worth $1,135,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Family Firm Inc. acquired a new position in Mettler-Toledo International during the second quarter worth $25,000. Mather Group LLC. acquired a new position in Mettler-Toledo International in the first quarter valued at about $32,000. Rothschild Investment LLC purchased a new stake in Mettler-Toledo International during the second quarter worth about $42,000. Itau Unibanco Holding S.A. purchased a new stake in shares of Mettler-Toledo International during the second quarter worth approximately $42,000. Finally, Crewe Advisors LLC increased its stake in shares of Mettler-Toledo International by 244.4% during the second quarter. Crewe Advisors LLC now owns 31 shares of the medical instruments supplier’s stock worth $43,000 after buying an additional 22 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the transaction, the insider now directly owns 734 shares of the company’s stock, valued at $1,044,459.98. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the sale, the chief financial officer now directly owns 4,914 shares in the company, valued at $6,884,514. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total value of $1,422,970.00. Following the sale, the insider now owns 734 shares in the company, valued at $1,044,459.98. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Mettler-Toledo International Trading Up 0.7 %

Shares of NYSE:MTD opened at $1,373.98 on Monday. The stock’s 50-day moving average price is $1,424.61 and its two-hundred day moving average price is $1,394.17. Mettler-Toledo International Inc. has a 12-month low of $928.49 and a 12-month high of $1,546.93. The firm has a market cap of $29.34 billion, a price-to-earnings ratio of 38.53, a PEG ratio of 4.24 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.00 by $0.65. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The firm had revenue of $946.75 million for the quarter, compared to analyst estimates of $929.13 million. During the same period last year, the company earned $10.19 EPS. The firm’s quarterly revenue was down 3.6% on a year-over-year basis. As a group, research analysts forecast that Mettler-Toledo International Inc. will post 40.35 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have commented on MTD shares. JPMorgan Chase & Co. increased their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Stifel Nicolaus raised their target price on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a report on Monday, August 5th. Evercore ISI raised their target price on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Wells Fargo & Company assumed coverage on Mettler-Toledo International in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price target for the company. Finally, StockNews.com upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Thursday, July 11th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $1,363.75.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.